The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Abbott India

30591.50
-510.35 (1.64%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events

Performance

Open
31,100.00
Prev. Close
31,101.85
Volume
8,589
Total traded value
26.28 Cr
Upper Circuit
37,322.20
Lower Circuit
24,881.50

Analyst Estimates

83%
Buy
83%
Hold
0%
Sell
17%
Aggregated by Refinitiv from 6 Analysts

Fundamentals

Market Cap₹66,040Cr
ROE36.48%
P/E Ratio(TTM)49.49
EPS(TTM)627.98
P/B Ratio18.76
Dividend Yield1.32%
Industry P/E43.42
Book Value1656.99
Debt to Equity0.02
Face Value10
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
1,4931,5201,6251,6931,686Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Abbott India

Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.;
Parent OrganisationAbbott India Limited
Managing DirectorMr. Vivek Kamath
NSE SymbolABBOTINDIA

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Promoters
74.99%
Retail And Others
15.84%
Mutual Funds
7.77%
Other Domestic Institutions
1.23%
Foreign Institutions
0.16%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
GlaxoSmithKline Pharmaceuticals
NA
(0.00%)
55.89
Astrazeneca Pharma India
NA
(0.00%)
217.46
Pfizer
NA
(0.00%)
30.39
Sanofi India
NA
(0.00%)
33.96
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW